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Medicare NCDs were equivalent to the corresponding private payer policies in 
51% of cases, more restrictive in 23%, less restrictive in 22%, and varied in 4%. 
Independence Blue Cross Group was the payer most often consistent with Medicare 
(82%), and WellPoint least often consistent (25%). We found little difference between 
510(k) cleared and PMA approved devices, although NCDs were more often less 
restrictive than the private payer policy for PMA approved devices than for 510(k) 
cleared devices (31% vs. 17%). We found few differences among devices by clinical 
indication. CONCLUSIONS: Medicare coverage of medical devices in NCDs is often 
inconsistent with coverage by private payers. For patients, this inconsistency means 
variable access to medical technology, and patients transitioning between health 
plans may face discontinuity of care. For industry, inconsistent coverage policy 
among payers adds uncertainty when designing clinical development programs, 
and when bringing innovations to market.
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OBJECTIVES: Due to the introduction of health exchanges in 2014, more than 7 
million Americans have gained access to commercial insurance. However, the per-
centage of potential enrollees covered by exchange-based plans varies widely by 
state. This study assesses the impact of economic, political, insurance industry 
and demographic variables on enrollment in plans offered on the exchanges, to 
identify the key factors likely to influence use of this more-affordable healthcare 
channel long term. METHODS: Enrollment in state-based exchange plans, par-
ticipation metrics, costs, and marketplace factors were obtained via census of 
148 U.S. health insurers. Demographic information was procured from the U.S. 
Census Bureau, and state-based political leanings were garnered from 2012 elec-
tion results. RESULTS: Correlation tests show that no single variable predominantly 
drove enrollment in exchange-based plans in 2014, but instead reveal a number of 
influential factors working in unison. Enrollment at the state level correlated most 
positively with median age, possession of a bachelor’s degree or higher, and 2012 
presidential votes secured by President Obama. The average premium for com-
mercial coverage in states prior to the launch of exchanges showed a weaker posi-
tive correlation. The strongest negative correlations were average family size and 
higher uninsured rate at the time of healthcare reform. Business-related issues, 
such as the competitive mix in states and participation in exchanges, had limited 
impact. CONCLUSIONS: Enrollment in exchange-based healthcare plans in 2014 
was driven by a number of factors, none of which predominated. Data suggest that 
enrollment in exchanges outperformed in states comprising older, better-educated, 
and more liberal Americans, a group likely already predisposed to favor healthcare 
reform. Conversely, enrollment was lower in states housing larger families, and 
more uninsured citizens to start with. Overall, demographic rather than economic 
issues directly look set to drive participation in exchange-based health insurance 
in future years.
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OBJECTIVES: Global economies are still in recovery from the financial crisis, and 
both mature and emerging markets will need to continuously innovate and launch 
new products and services to succeed in the future. Developed markets have tra-
ditionally been the source of most biopharmaceutical innovations as well as the 
destination for the resulting health and economic benefits and there is a gap in 
research on emerging markets in this sector.[1] We sought to assess the level of 
innovation in the BRICs markets (Brazil, Russia, India, China) compared to the top 
five mature economies by GDP (United States, Japan, Germany, France, and the 
United Kingdom). METHODS: We indexed the nine countries across seven innova-
tion indicators (high technology exports (in USD, and as a percentage of manufac-
tured exports), patent applications, revenue received for use of intellectual property, 
R&D expenditure, R&D workforce, and scientific/technical journal articles), based 
on 10-year trends from 2003 to 2012. These indices were then used to calculate an 
innovation score for each country. RESULTS: Among the target established markets, 
France and Germany were tied for highest overall growth in innovation, followed by 
the US, then UK, and Japan. China was the clear innovation leader among emerging 
markets followed by India, then Brazil, and Russia. Overall, with the exception of 
Russia, emerging markets scored better than the established markets. China ranked 
first overall, India second and Brazil third while Russia was eighth only beating out 
Japan which took ninth place overall. CONCLUSIONS: While established markets 
have traditionally been thought to drive technological advances, emerging BRICs 
markets have thriving innovation landscapes and in future may play a significant 
role in the biopharmaceutical innovation landscape. [1] Rezaie R et al. “Emergence 
of biopharmaceutical innovators in China, India, Brazil, and South Africa as global 
competitors and collaborators”. Health Res Policy Syst. 2012; 10: 18.
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OBJECTIVES: Pharmacist collaborative drug therapy management (CDTM) in U.S. 
hospitals has room for growth despite regulations recognizing the practice and evi-
dence of CDTM improving patient outcomes. This study’s objectives were to 1) assess 
pharmacy directors’ perceptions of CDTM, and 2) compare current opinions of CDTM 
to those 10 years prior. METHODS: A self-administered written survey was mailed 
use CAM compared to men. The factors associated with CAM use were different for 
men and women. Medical providers may need to counsel women about the effec-
tiveness of CAM to treat their chronic conditions. Future research needs to evaluate 
the effectiveness of CAM therapies among women with multiple chronic conditions.
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OBJECTIVES: Integrated delivery models in the outpatient setting such as Medical 
Homes (MHs) require effective interprofessional communication and collaborative 
practice. Our objective was to evaluate the attitudes towards collaboration of nurses, 
general practitioners (GPs), and specialists practicing in newly established MHs in 
the Parma Local Health Authority, Italy. METHODS: The 15 item Jefferson Scale of 
Attitudes Toward Physician-Nurse Collaboration was administered electronically to 
172 physicians (66 GPs, 106 specialists) and 113 nurses practicing in 12 MHs, caring 
for an overall population of about 90,000 patients. Possible scores of the scale range 
from 15 to 60 with higher scores representing a more positive attitude toward col-
laboration. The scale also contains three factors that measure: a) shared education 
and teamwork; b) caring versus curing; c) physician authority. Categorical variables 
were compared with Chi square or Fisher’s exact tests; continuous variables were 
compared using t-tests or ANOVA, as appropriate. RESULTS: A total of 191 surveys 
(45 GPs, 59 specialists, 87 nurses) were completed for an overall 67% response rate. 
The mean total score among nurses (51.5, Standard Deviation 3.7) reflected a sig-
nificantly (p< 0.01) more positive attitude towards collaboration compared with GPs 
(47.8, SD 4.6) and specialists (45.3, SD 7.7). This hierarchy was observed consistently 
for all three factors with the exception of physician authority, upon which general 
practitioners’ and specialists’ each expressed strong perceptions of nurses as assis-
tants rather than collaborators. CONCLUSIONS: Nurses consistently conveyed posi-
tive responses, indicative of a willingness to collaborate and to take on additional 
responsibility within the MH environment in Parma Local Health Authority. GPs and 
specialists responded in agreement with most items, although lower scores sug-
gested a relative temperate attitude towards physician-nurse collaboration. Further 
research into interprofessional relationships within MHs is needed to inform policy 
and develop educational initiatives to build a necessary culture of team-based care.
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OBJECTIVES: Cost-utility analysis (CUA) has been extensively used to assess and 
convey health care intervention costs and health benefits. We examined the growth 
and characteristics of published English-language CUAs through 2012. METHODS: 
We analyzed data from the Tufts Medical Center Cost-Effectiveness Analysis 
Registry (www.cearegisty.org), which contains detailed information on more than 
4,000 English-language CUAs published in peer-reviewed journals. We summarized 
study intervention types, disease areas researched, funding sources, journals of 
publication and methodological practices over three time periods: 1990-1999, 
2000-2009, and 2010-2012. We also investigated the extent to which the number 
of CUAs focusing on each of several worldwide geographic regions was corre-
lated with regional disease burden. RESULTS: The number of CUAs published 
steadily increased over time, from 34 annually during the 1990s to 431 annually 
during 2010-2012. The number of CUAs published during 2012 (n= 538) exceeded 
the number published in 2011 (n= 372) by 45%. The proportion of CUAs targeting 
the US population declined from 61% during 1990-1999 to 35% during 2010-2012 
(p< 0.0001). Most interventions have focused on pharmaceuticals (47%), followed 
by surgery (13%), screening (12%) and medical procedures (12%). Of the diseases 
researched, cardiovascular disease is the most common (18% of all studies), fol-
lowed by cancer (15%) and infectious diseases (15%). During 1990-2012, 51% of 
CUAs performed probabilistic sensitivity analyses and 33% included acceptability 
curves. The proportion of CUAs funded by the drug industry varies substantially 
across journals. Investigators in low- and middle-income countries contributed 
an increasing number of published CUAs in recent years. Across all geographic 
regions, few CUAs have focused on injuries relative to their population bur-
den. CONCLUSIONS: Our review reveals considerable growth and some change 
in the cost-utility literature in recent years. The data suggest growing interest in 
cost-utility methodology, particularly in developing countries.
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OBJECTIVES: To determine the consistency of Medicare coverage of medical devices 
in national coverage determinations (NCDs) with coverage policies issued by U.S. 
private payers. METHODS: We used the Tufts Medical Center Medicare National 
Coverage Determination Database to identify medical devices considered in NCDs 
from 1999-2013. We categorized each device with respect to its FDA approval path-
way and clinical application(s). We compared coverage in the NCD with coverage 
in equivalent policies issued by the 16 largest private U.S. payers that make their 
policies publicly available. We categorized each NCD as: equivalent to the private 
payer policy; more restrictive than the private payer policy; less restrictive than the 
private payer policy; or, when restrictiveness differed across considered indications, 
as varied. RESULTS: Medicare considered 47 medical devices through NCDs. We 
identified 540 coverage policies issued by private payers for the included devices. 
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OBJECTIVES: A new drug application authorized generic (AG) has the same active 
and inactive ingredients as the brand and it is marketed under a different labeler 
code, product code, trade name, trademark, or packaging (other than repackag-
ing) than the brand. Authorized generics compete in price with generic drugs. 
We assessed trends in the marketing of authorized generics in the US in the 
period 1982-November 2014. METHODS: Data were derived from the FDA data-
bases: “Database for Authorized Generic Drugs,” National Drug Code, Online Label 
Repository, and Approved Drug Products with Therapeutic Equivalence Evaluations. 
Time trends in generic marketing were described and compared with chi-square 
tests. RESULTS: In November 2014, the FDA listed 2301 approved active ingredients 
and combinations, with 3686 route/dosage forms and 7932 strengths. There were 296 
generic drugs approved before 1982, 195 in 1982-1989, 140 in the 1990s, 285 in the 
2000s, and 175 in 2010-Nov 2014. By November 2014, 47.4% of FDA approved active 
ingredients and combinations had generic competition, 22.00% were discontinued 
without generic competition, 10.8% did not have patent or exclusivity protection 
and did not have generic competition, and 19.7% were under patent or exclusivity 
protection. A total of 36.4% of the active ingredients/combinations with generic 
competition had at least one AG. AGs were marketed for 29% of the route/dosage 
forms and 27.4% of the strengths with generic competition. The percentage of active 
ingredients/combinations with generic competition and AG significantly increased 
from 15.5% before 1982, to 28.2% in 1982-1989, 47.1% in the 1990s, and 54.6% in the 
2000s, and 38.9% in 2010-Sep 2014 (p< 0.05). CONCLUSIONS: A significant percent-
age of generic drugs experienced the entrance of an authorized generic. The use of 
authorized generics increased overtime. The effect of authorized generics on the 
generic market and the incentives for generic entry should be assessed.
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OBJECTIVES: To assess the perception of health sciences students of southern 
Karnataka towards generic drugs. METHODS: The study was performed over a 
period of one month through one to one structured surveys with a random sample 
of 200. The response was analyzed by descriptive and frequency statistics using 
SPSS ver. 20. RESULTS: Out of the 200 questionnaires administered 183 responded 
with response rate of 91.50% and mean age of 23.64 ± 3.20. Out of total respond-
ents 47 % were undergraduates and 45.4% were postgraduates. 54.6 % students 
were from medical sciences followed by 23 % from allied health sciences and 9.8 % 
from pharmaceutical sciences. The knowledge was assessed and 34.5 % agreed that 
brand name drugs are of better quality than generic drugs while 38.3 % disagreed. 
40.5% disagreed that brand name drugs were more effective than generic medicines 
and 32.1 % were unsure. 44.2 % students disagreed that generic drugs have more 
side effects than brand name drugs while 15.3 % agreed. Finally 71.1% agreed that 
generic drugs were less expensive than brand name drugs. Attitude towards the 
generic drugs was also assessed. Prescribing generic drugs will reduce the treat-
ment cost and cost related non-compliance was agreed upon by 74.9 % and 78.7 
% students respectively. 81.4% agreed that increased use of generic medicine will 
reduce unethical marketing practices by Pharmaceutical companies. 80.8 % agreed 
that more policies should be framed to promote generics prescriptions and 85.3 % 
believed that the community pharmacist can play important role to promote the 
use. CONCLUSIONS: In a country like India where brand name drugs have an upper 
hand the attitude of younger breed of professionals is encouraging but on a contrast 
the knowledge was low and many resorted to be unsure on various basic aspects.
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OBJECTIVES: Since the increasing threat of community-associated resistant organ-
isms, emphasis has been placed on increasing education and awareness for clini-
cians and the public regarding appropriate antibiotic use and antibiotic resistance 
through community-based initiatives. Teachers and students are a significant group 
as they can influence the society effectively. This qualitative study was undertaken 
to find out their perception and knowledge about antibiotic use, antimicrobial 
resistance (AMR) and suggestions for practical interventions for rational use of 
antibiotics. METHODS: Focus group discussions (FGDs) with high school students 
and teachers were conducted in five municipal wards of Delhi in five schools (2 
private and 3 public). Data on antibiotic knowledge, resistance, and behaviors with 
respect to antibiotics use were collected. Students were also asked to answer four 
basic questions on antibiotic knowledge. The FGDs (n= 5 for each group; teach-
ers= 4-8 and students= 15-22 participants/FGD) were analyzed using ‘thematic 
analysis’. RESULTS: Students had extremely poor knowledge regarding antibiot-
ics and antimicrobial resistance, while only some teachers had a very rudimen-
tary understanding. Four broad themes needing attention emerged during FGDs: 
definition of antibiotic; usage of antibiotics in different conditions, including fever 
and diarrhea; role of doctors in informing patients about antibiotic usage; inter-
ventions and strategies for rational use of antibiotics. These results were further 
divided into various sub-themes depending upon responses of each group. In order 
to tackle these problems, both groups suggested a multi-pronged approach includ-
ing, robust awareness campaigns, better doctor-patient relationships and stronger 
regulations. CONCLUSIONS: Though high school students and teachers in Delhi 
showed poor awareness about antibiotic use and resistance, they exhibited a keen 
interest in learning about these issues. Their awareness levels can be targeted using 
health communication methods to shape correct perceptions about antibiotic use, 
containment of AMR and thus preservation of antibiotics for future generations.
to a national random sample of hospitals stratified by number of hospitals per state. 
Pharmacy directors’ opinions on CDTM were assessed using four scales: Perceived 
Support for CDTM, Financial Impact on Pharmacy, Strategic Impact on Pharmacy 
and Effect of Regulations on CDTM. Respondents rated items on a 5-point Likert 
scale where 1= strongly disagree, 2= disagree, 3= neutral, 4= agree, and 5= strongly 
agree. Scales were scored so higher scores represented more positive perceptions 
of CDTM. Possible scores ranged from 1-5. Means and standard deviations were 
calculated for each scale. ANOVA compared current scale scores to scale scores 
reported in 2003. Two open-ended questions asked respondents to identify barriers 
and facilitators to CDTM. Content analysis identified common themes. RESULTS: 
1,024 surveys were mailed. 70 were returned undeliverable. 7 were returned incom-
plete, yielding 286 usable surveys from 947 assumed delivered (30.2 percent). Based 
on mean±standard deviation scale scores, respondents perceived CDTM had good 
support (3.9±0.4), positive strategic impact (3.8±0.5), little or no financial impact on 
pharmacy (2.9±0.8), and were neutral regarding CDTM regulations (2.7±0.7). No sig-
nificant difference was seen in any mean scale score as compared to 2003 (p> 0.05). 
Physician support was the most often mentioned facilitator of CDTM (42.2 percent) 
and also the most often mentioned barrier (33.8 percent) to CDTM. CONCLUSIONS: 
Pharmacy directors feel CDTM is supported by hospital staff and has positive strate-
gic impact in facilitating the implementation of pharmacy services. These positive 
perceptions of CDTM have been maintained over the last decade.
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OBJECTIVES: To determine the optimal capacity and workflow processes of the 
Outpatient Surgery Center (OSC) for a rural hospital based on the future demand, 
redesigned care processes, and current available technologies using the Discrete Event 
Simulation (DES) method. METHODS: Planning for health care delivery services is 
extremely complex due to the involvement and interactions of people, facility, pro-
cess, and technology. Making data-driven decisions, while customizing care to the 
needs of individual patients and family, is critical to efficiently delivering patient-
centered care. We employed the Discrete Event Simulation (DES) method to optimize 
the future bed capacity based on the projected demands. Workflow improvements, 
that were necessary to meet efficiency optimization and desired patient experience 
for future success of the OSC, were also identified. The planning team developed a 
future state floor plan that met the needs of the patients and staff based on a set of 
assumptions. Locations of rooms, resources, and optimal workflows were determined 
through data collected from observations and time studies of outpatient surgery 
holding rooms, treatment rooms, and operating rooms. Patient tracks were modeled 
within the simulation from the collected data which generated a real-world view of 
patient flow through the system. RESULTS: The simulation allowed for the utilization 
of current time study data to determine how changes impacted the future output 
metrics and care processes using a new floor plan. By running the simulations with an 
improved room turnover process and an increased patient volume, it was concluded 
that the optimal number of outpatient surgery beds was 17 instead of the 22 beds 
that were recommended by the marketing and planning department. CONCLUSIONS: 
The optimal bed capacity allows for potential future growth and would maximize 
room utilization by limiting the number of idle rooms (idle rooms waste healthcare 
resources) while providing the best patient experience.
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OBJECTIVES: The objective was to establish whether the level of education of the 
head of household influences ownership and use of mosquito treated nets among 
household members. Ownership and use of treated nets has been shown to be an 
effective method of reducing malaria transmission. Scaling up the use of treated 
nets in order to protect < 5 years children and pregnant women against malaria 
was one of the targets set by African Heads of States in Abuja Declaration in 2000. 
In Kenya, various mechanisms including mass campaigns and distribution of 
nets in hospital clinics have been used to make the nets accessible. METHODS: 
A household baseline survey was carried out in Western Kenya in which 1620 
heads of households were interviewed. A total of 8848 people among them heads 
of households, spouses, children by birth, children by relationship, grand-chil-
dren, house-help and other relatives in the household were included in the study. 
Heads of households were asked whether they owned treated mosquito nets and 
state the number of household members by relationship that slept under treated 
mosquito nets the night preceding the survey. RESULTS: The study showed that 
98 % (1584/1620) of the heads of households interviewed, 94% (1489) said they 
owned nets. Ninety percent (82/91) had no education; primary education, 92 
%( 1240/1348); secondary education, 93 %(134/144); and tertiary education and 
above, 100%(26/26). Similar trend was observed also in the use of treated mosquito 
nets. CONCLUSIONS: It was concluded that the level of education does influence 
ownership and use of mosquito nets among members of households .The pro-
portion of ownership and use of treated mosquito nets increased as the level of 
education increased. However, there is need to investigate the effect of age, main 
source of income and relationship to head of household among other factors in 
order to get a better understanding.
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